Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-59
SponsorStanford University

About this trial

We are enrolling participants aged 22 and older to have LASIK surgery in both eyes. We will perform wavefront-guided LASIK in one eye and ray tracing-guided LASIK in the fellow eye of each participant. We are trying to see if there are any differences in the efficacy between the two types of LASIK procedures.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 22 and older

No abnormal corneal shape

No excessively thin corneas

No eye diseases such as glaucoma or cataracts

Disqualifiers

Subjects under the age of 22.

Subjects with excessively thin corneas.

Subjects with topographic evidence of keratoconus.

Subjects with ectactic eye disorders.

Trial design

Design model

Single group

Treatments tested in this trial

  • LASIK

    Procedure/Surgery

    Wavefront-guided LASIK is being performed in one eye and Ray-tracing guided LASIK is being performed in the fellow eye

  • LASIK

    Procedure/Surgery

    Ray-tracing guided LASIK is being performed in one eye and Wavefront-guided LASIK is being performed in the fellow eye.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Wavefront-guided laser ablationActive comparator 1 intervention
Group B: Ray tracing-guided LASIKActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Uncorrected visual acuity

Uncorrected visual acuity using ETDRS charts

Time frame
One year

Secondary outcomes

1

5 and 25% best corrected low contrast visual acuity

Measurement of the change in 5 and 25% best corrected low contrast visual acuity using ETDRS charts

Time frame
12 months
2

Achieved versus attempted ablation depth measured by anterior segment OCT

Measurement of achieved ablation depth by comparing preoperative anterior segment OCT to postoperative anterior segment OCT

Time frame
One, three and twelve months
3

Self reported quality of vision and quality of life measures

A validated questionnaire will be administered preoperatively and at postoperative months 3, 6 and 12

Time frame
Three, six and twelve months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.